PRIVATE FUNDS

208 Form D Notices Indexed September 28, 2026, Including Filings From Pfaradigm Health and Vertical Longevity Pharmaceuticals

Regulatory filings indexed on September 28, 2026, include 135 new notices and 73 amendments. The registry captures cumulative offering totals reported by issuers across diverse industry groups, including health care and biotechnology.

By Daniel Mercer··2 min read

The daily index of Form D notices for September 28, 2026, reflects a total of 208 filings. This figure includes 135 new notices and 73 amendments indexed during the day. The index captures a variety of issuer types and industries, with notices filed as observations of activity rather than as a single sector or offering trend.

Reported offering amounts represent the cumulative total as stated in each individual filing, rather than the amount of capital raised on the index date itself. Individual notices may contain earlier filing dates, and issuer identity as well as signatory roles are presented as filed by the entities.

[PFARADIGM Health, Inc.](#issuer:2156162), a corporation incorporated in Delaware, filed a notice indexed on September 28, 2026. The filing categorizes the issuer under the Other Health Care industry group. The document lists Allan Zingeler as the chief executive officer and director who signed the notice on September 25, 2026.

The PFARADIGM Health, Inc. filing reports a total offering amount of $56.1M. The document indicates that $31.1M has been sold, with $25.0M remaining. These figures reflect the cumulative totals as reported in the current filing, not money raised during the reporting day.

[Vertical Longevity Pharmaceuticals, Inc.](#issuer:2087846), another Delaware-incorporated corporation, submitted a notice indexed on September 28, 2026. This issuer is classified under the Biotechnology industry. The filing names David P. Scieszka, whose title is reported in the filing as CEO, as the signatory. He signed the document on September 25, 2026.

Vertical Longevity Pharmaceuticals, Inc. reports a cumulative total offering amount of $0.1M in its latest filing. The notice indicates the total amount sold is $0.1M, with $0 remaining to be sold. As with all index entries, these amounts are cumulative as reported in this filing.

CategoryCount
New notices135
Amendments73

Download data (CSV)

Complete filing list

All 208 Form D notices in the covered daily index, listed alphabetically by issuer. The filing date is preserved as reported; a daily index can include a notice with an earlier filing date. Each row links to its SEC filing.

Showing rows 76–100 of 208. The CSV contains the complete table.

IssuerFiling dateDaily index dateFormAccessionSEC filing
Eca Boulware LLC09/28/202609/28/2026D0002150562-26-000001View filing
Eca Chateau LLC09/28/202609/28/2026D0002150573-26-000001View filing
Eca Longview TX LLC09/28/202609/28/2026D0002150538-26-000001View filing
Ecp O13, LLC09/28/202609/28/2026D0002074922-26-000001View filing
Emmi Health, Inc09/28/202609/28/2026D0002156262-26-000001View filing
EquityZen Growth Technology Fund LLC - Series 237509/28/202609/28/2026D0002139212-26-000001View filing
Escalate Capital V, LP09/28/202609/28/2026D0002093839-26-000003View filing
Evia Bio, Inc.09/28/202609/28/2026D0001954759-26-000004View filing
Evoke Innovation Fund II, LP09/28/202609/28/2026D/A0002092610-26-000003View filing
Evoke Royalty Solutions Fund II (Oberland), LP09/28/202609/28/2026D/A0002092617-26-000002View filing
Evoke Secondaries Fund VI (BR VI), LP09/28/202609/28/2026D/A0002072410-26-000002View filing
Exa Labs Inc.09/28/202609/28/2026D0002024864-26-000003View filing
Expedition Function Co-Invest LP09/28/202609/28/2026D0001315863-26-000693View filing
Ffe SPV I LLC09/28/202609/28/2026D0002153805-26-000001View filing
Fieldpoint Private Holdings, Inc.09/28/202609/28/2026D0001870391-26-000002View filing
Foundational Fund, LP09/28/202609/28/2026D/A0001996520-26-000001View filing
Frequency Exchange Corp.09/28/202609/28/2026D0001816133-26-000001View filing
Full Stop Holdings LLC09/28/202609/28/2026D0002157033-26-000001View filing
Gaingels AllJoined LLC09/28/202609/28/2026D0002147616-26-000001View filing
Gaingels Firehawk August 2026 LLC09/28/202609/28/2026D0002151565-26-000001View filing
Gaingels Palabra AI LLC09/28/202609/28/2026D0002154903-26-000001View filing
Gemspring Growth Solutions Executive II, LP09/28/202609/28/2026D/A0000905148-26-004274View filing
Gen AI Fund H a Series of Fog Ventures Fund III LLC09/28/202609/28/2026D0002156927-26-000001View filing
GID Commercial Real Estate Credit Fund LP09/28/202609/28/2026D/A0002088816-26-000001View filing
Glean IP Holdings Inc.09/28/202609/28/2026D/A0002088694-26-000001View filing

Download data (CSV)

Sources